Business Wire

Chinese Tourists Can Now Pay with Alipay at More Than 300,000 Merchants in Japan, Six Times More Than a Year Ago

Del

Alipay, the world’s leading payment and lifestyle platform operated by Ant Financial, has connected more than 300,000 Japanese merchants as of early 2019 with tourists from Chinese mainland paying through the Alipay app.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190514005435/en/

A pharmacy in Tokyo accepting Alipay.

A pharmacy in Tokyo accepting Alipay.

This was an increase of about 500 percent compared with the beginning of 2018, when 50,000 merchants in Japan accepted Alipay, amid a push by the Japanese government to drive greater adoption of mobile payments.1

Japan is one of the most popular destinations for holiday by Chinese tourists, according to statistics compiled by Alipay, which is also working with its e-wallet strategic partners in other Asian markets to bring more consumers to Japan in the near future. Alipay’s e-wallet partners include TrueMoney in Thailand, GCash in the Philippines, kakaopay in the Republic of Korea, and Paytm in India.

Over China’s the four-day long Labour Day holidays in early May, Japan was ranked fourth highest among all the overseas destinations in terms of total Alipay transaction volume. The country also posted one of the biggest increases in tourist spending, with average spending on Alipay per person rising 25% year-on-year. During the period, the most popular merchants for shoppers were convenience stores, airport shops, and department stores, according to Alipay statistics.

More tourists are expected to visit Japan in the coming years and Alipay is working to help local merchants cope with the influx through digital payments, while providing tourists with the mobile payment experience that they are familiar with back home. 2

For example, users of AlipayHK - the e-wallet for Hong Kong citizens jointly developed by Alipay and CKHH - can now use the e-wallets in the Daimaru Tenjin store in Fukuoka, with the service expected to expand to the whole of Japan in the near future.

“Alipay has been providing technology support to our nine e-wallet partners to enhance their cross-border payment capabilities, and hopefully to bring more Asian customers to Japan and contribute to revitalizing the local economy,” said Eric Jing, Chairman and CEO of Ant Financial.

“We are dedicated to supporting small and micro businesses around the world through our technology. Digital wallets like Alipay are not only convenient payment tools, but also smart marketing platforms to connect merchants and their potential customers before, during and after their visits to Japan,” Eric added.

Nearly 60 per cent of overseas bricks-and-mortar merchants that adopted Alipay saw a subsequent growth in both foot traffic and revenue, according to the report 2018 Trends for Mobile Payment in Chinese Outbound Tourism by Nielsen. A separate report, Outbound Chinese Tourism andConsumption Trend: 2017 Survey, found that over 90% of Chinese tourists would use mobile payment while traveling overseas if they were given the option.

China is the largest tourism market for Japan, accounting for 27% percent of the 31 million tourists who visited the country in 2018. Tourists from Asia as a whole reached 26 million last year, accounting for more than 86% of Japan’s total visitor number.3

About Alipay

Operated by Ant Financial Services Group, Alipay is the world’s leading payment and lifestyle platform. Launched in 2004, Alipay currently serves over 1 billion users with its local e-wallets partners. Over the years, Alipay has evolved from a digital wallet to a lifestyle enabler. Users can hail a taxi, book a hotel, buy movie tickets, pay utility bills, make appointments with doctors, or purchase wealth management products directly from within the app. In addition to online payments, Alipay is expanding to in-store offline payments both inside and outside of China. Alipay’s in-store payment service covers over 50 markets across the world, and tax reimbursement via Alipay is supported in 35 markets. Alipay works with over 250 overseas financial institutions and payment solution providers to enable cross-border payments for Chinese travelling overseas and overseas customers who purchase products from Chinese e-commerce sites. Alipay currently supports 27 currencies.

1 https://www.japantimes.co.jp/news/2018/12/03/reference/japan-grudgingly-heads-toward-cashless-society/#.XNpAf9MzbOQ

2 https://www.telegraph.co.uk/travel/destinations/asia/japan/articles/japan-fastest-growing-travel-destination/

3 https://www.jnto.go.jp/jpn/statistics/visitor_trends/index.html

Contact information

Xinyun Yang
+86 13816896301
xinyun.yang@antfin.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Knopp Biosciences Presents Positive Preclinical Data for Lead Neonatal Epilepsy Drug Candidate at 2019 Antiepileptic Drug and Device Trials XV Conference24.5.2019 14:00:00 CESTPressemelding

Knopp Biosciences LLC, a privately held drug discovery and development company focused on delivering breakthrough treatments for inflammatory and neurological diseases of high unmet need, today presented in vitro and in vivo data for the company’s lead molecule for the targeted treatment of KCNQ2-neonatal epileptic encephalopathy (KCNQ2-NEE) at the Antiepileptic Drug and Device Trials XV Conference in Miami, Florida. KCNQ2-NEE, a rare infant genetic epilepsy, results from mutations in genes encoding the Kv7.2/Kv7.3 ion channel, leading to frequent seizures and profound developmental delay. The preclinical data were presented by Steven Dworetzky, Ph.D., Knopp’s Chief Scientific Officer, a longtime Kv7 researcher who led the group that first cloned the Kv7.2 and Kv7.3 genes during his former tenure with the Bristol-Myers Squibb Co. Dr. Dworetzky presented results demonstrating the in vitro nanomolar activity of KB-3061 and its significant seizure protection in the maximal electroshock mo

Accelerate Your Business in South Korea Through 2019 K-Startup Grand Challenge24.5.2019 10:20:00 CESTPressemelding

Entrepreneurs from across the globe should set their sights on participating in the 2019 K-Startup Grand Challenge. Supported by the Ministry of SMEs and Startups and National IT Industry Promotion Agency (NIPA) of South Korea, the initiative provides invaluable support and comprehensive resources to early age startups. Applications for the K-Startup Grand Challenge are currently being accepted through June 14, 2019. In order to advance in the program, teams must pass a regional audition. A judging panel of startup ecosystem experts and Korean accelerators will select 40 teams to participate in an enriching 3.5 month-long acceleration program in Korea. The selected teams will have exclusive access to free office space at the Startup Campus in Pangyo Techno Valley, one-on-one mentoring, information sessions, coaching on Korean and Asian business culture and the chance to attend insightful seminars on accounting regulations to tax laws, patents and more. Opportunities for networking with

New Investigational Clinical Data for Ipsen’s Oncology Products in 11 Solid Tumor Types to Be Presented at 2019 ASCO Annual Meeting24.5.2019 05:00:00 CESTPressemelding

Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that new data from clinical studies on investigational uses of cancer medicines cabozantinib (Cabometyx®), liposomal irinotecan (Onivyde®), and lanreotide autogel (Somatuline®, marketed as Somatuline Depot® in the United States) will be presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting. The meeting takes place in Chicago, Illinois, U.S., 31 May–4 June 2019; data featuring Ipsen medicines includes: New data from the Phase 3 CELESTIAL trial on the association of adverse events with efficacy outcomes for cabozantinib in patients with advanced hepatocellular carcinoma Overview of the Phase 3 COSMIC-312 trial of cabozantinib in combination with atezolizumab vs sorafenib in patients with advanced hepatocellular carcinoma who have not received previous systemic anticancer therapy First Phase 2 data from the CaboGIST study (trial 1317) from the European Organization for Research and Treatment of

The Posiflex Group Showcases an Ecosystem of Connected Solution Endpoints with IoT Remote Monitoring at Computex 201924.5.2019 01:00:00 CESTPressemelding

For the Computex 2019 show, The Posiflex Group is featuring leading solution technology from the family of brands as a fully Serviced IoT Ecosystem. Solution end points include: Connected Modular Kiosks, POS Terminals, and Digital Signage solutions from Posiflex and KIOSK Information Systems Smart Medical Displays with gesture controls from Portwell Connected Gaming Solutions with Player Tracking Technology from Portwell subsidiary, Ganlot The booth display is based on common field service endpoints represented in a European Manor Destination Resort setting. Field solutions for an array of vertical market applications include QSR ordering, cinema ticketing, fashion retail customer loyalty, interactive signage, hotel / medical center check-in and bill pay, as well as casino gaming technology. This year, in addition to their renowned POS product suite, Posiflex will be featuring newly introduced Modular Kiosk platforms (co-designed by KIOSK and Posiflex), which are configure-to-order sta

Audi China President Thomas Owsianski to Keynote at CES Asia 201923.5.2019 20:00:00 CESTPressemelding

The Consumer Technology Association (CTA)TM today announced that Thomas Owsianski, president of Audi China, will deliver a keynote address at the upcoming CES Asia 2019. Now in its fifth year, CES Asia will run June 11-13, 2019 at the Shanghai New International Expo Centre (SNIEC) in Shanghai, China. Thomas Owsianski’s keynote is scheduled for 4 PM, Tuesday, June 11, where he will unveil Audi’s vision in transforming mobility from a driving experience to a digital adventure. Mr. Owsianski joined the top management team of Audi China in August 2018 and was named President in October 2018. “Audi has been at the forefront of driving global transformation in the automotive industry through their breakthrough advancements in technology,” said Karen Chupka, executive vice president, CES. “Innovation has revolutionized the transportation experience, and we welcome Mr. Owsianski to the CES Asia stage to share Audi’s vision for the future of global mobility.” Throughout Asia and beyond, technol

ITechLaw Publishes New Book and Opens Global Public Comment Period on Draft Principles for Responsible Artificial Intelligence23.5.2019 19:11:00 CESTPressemelding

The International Technology Law Association (ITechLaw) has published Responsible AI: A Global Policy Framework, a new book that provides an in-depth review and eight discussion principles that address some of the hottest technology and moral issues of responsible development, deployment and use of artificial intelligence. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190523005752/en/ ITechLaw releases new book, Responsible AI: A Global Policy Framework, and opens public comment period. (Photo: Business Wire) Written by a multi-disciplinary group of 54 technology law experts, industry representatives and researchers from 16 countries, the book offers an actionable framework built on the following principles: Ethical Purpose and Societal Benefit, Accountability, Transparency and Explainability, Fairness and Non-discrimination, Safety and Reliability, Open Data and Fair Competition, Privacy, and AI and Intellectual Property.